Przeglad gastroenterologiczny
Cure8 research brief
Why This Matters
Perianal fistulas are a common, challenging Crohn's complication that often need combined medical and surgical care; understanding local practice patterns helps patients and clinicians anticipate typical treatments and gaps in coordinated care.
The study shows biologics and surgery are commonly used after standard therapy fails, and access delays (eg, MRI) can affect care.
Who Should Pay Attention
Patients with Crohn's disease and current or past perianal fistulas; clinicians (gastroenterologists, colorectal surgeons) involved in perianal disease management; care teams planning multidisciplinary services.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This article reports a retrospective nationwide study and clinician surveys from Poland describing diagnosis and management patterns for complex Crohn's perianal fistulas, including imaging use, common initial therapies, post-failure biologic use (infliximab, adalimumab, vedolizumab, ustekinumab), and surgical interventions (abscess drainage, setons, fistulectomy).
It highlights inconsistent interdisciplinary coordination and access barriers (MRI wait times, specialized centres).
Keep In Mind
This is a retrospective chart review plus clinician surveys (Poland, data through 2023) summarized here as an abstract. It describes patterns of care and reported barriers but does not test interventions; findings reflect the surveyed centres and chart cohort and may not generalize to other healthcare systems.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationPrzeglad gastroenterologiczny
AuthorsEder P, Banasiewicz T, Głażewska J +4 more
Study typeJournal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedSep 21, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Postoperative Complications Associated with Advanced Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
People with IBD and clinicians often face decisions about whether to stop biologics or small molecules before abdominal surgery.
Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease
The study is comparing common biologics given after Crohn's surgery to prevent endoscopic recurrence—a key issue for people who have had bowel resection. Knowing which drugs perform better in real‑world practice could...
Beyond class switching in multi-refractory inflammatory bowel disease: Nine case reports and review of literature
For people with multi-refractory Crohn’s disease or ulcerative colitis, adding a JAK inhibitor to an existing biologic (advanced combination therapy) may convert partial responses into deeper remission in selected cases,...